These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2393882)

  • 1. [The effect of HLA alloimmunization and other factors on the effectiveness of thrombocyte concentrates].
    Pittrová H; Koza V; Cepelák V; Bufková D
    Cas Lek Cesk; 1990 Jun; 129(24):751-3. PubMed ID: 2393882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of antibody response to human platelet transfusion.
    Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
    J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
    Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effectiveness of thrombocyte concentrates in relation to the results of the lymphocytotoxicity test].
    Prazák J; Vítek A; Sejkorová J
    Cas Lek Cesk; 1990 Sep; 129(37):1172-5. PubMed ID: 2224981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
    MacPherson BR; Hammond PB; Maniscalco CA
    Ann Clin Lab Sci; 1986; 16(1):38-44. PubMed ID: 3947028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Substitution ofpolysensitized patients with platelets from HL-A typed single donors].
    Gmür J; Baumberger U; von Felten A
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1358-9. PubMed ID: 1006253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome.
    Kakaiya RM; Greenstein R; Pisciotto P; Slocum SK; Rosen D; Cable RG; Morse EE; Gainey A
    Ann Clin Lab Sci; 1985; 15(5):435-40. PubMed ID: 3933403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of clinical efficacy of platelet substitution in acute leukemia using resonance thrombography].
    Anders O; Ernst B; Hess G; Konrad H; Lakner V; Seyfarth M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):587-93. PubMed ID: 2414188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can thrombocyte crossmatching improve the efficiency of platelet transfusion?].
    Weisbach V; Zeiler T; Zingsem J; Musch R; Heuft HG; Eckstein R
    Beitr Infusionsther; 1990; 26():160-2. PubMed ID: 1703820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].
    Kubel M; Freistedt B; Hammer P; Thierbach V; Helbig W; Haustein B; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):355-64. PubMed ID: 6179839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombocyte substitution, 2: Thrombocyte preparations and determining the effectiveness of thrombocyte transfusion].
    Anders O; Preussner S; Konrad H
    Z Gesamte Inn Med; 1986 Dec; 41(23):647-51. PubMed ID: 3577256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombocyte replacement with HL-A typed non-related single donors].
    Cornu P; Groff P; Weber W; Nissen C; Burri HP; Speck B
    Schweiz Med Wochenschr; 1976 Jun; 106(26):889-93. PubMed ID: 792998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.